Profile data is unavailable for this security.
About the company
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
- Revenue in USD (TTM)13.64bn
- Net income in USD721.80m
- Incorporated1994
- Employees76.00k
- LocationDaVita Inc2000 16th StDENVER 80202-5158United StatesUSA
- Phone+1 (310) 536-2668
- Fax+1 (302) 636-5454
- Websitehttps://www.davita.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Radnet Inc | 1.97bn | -12.71m | 5.38bn | 8.55k | -- | 5.06 | 31.87 | 2.73 | -0.1828 | -0.1828 | 25.53 | 13.74 | 0.5676 | -- | 8.71 | 230,470.30 | 0.617 | 1.20 | 0.7907 | 1.59 | 21.33 | 22.02 | 1.09 | 1.90 | -- | 1.32 | 0.4549 | 0.00 | 13.18 | 9.65 | -8.25 | -28.32 | 20.46 | -- |
| Option Care Health Inc | 5.53bn | 209.21m | 5.50bn | 6.02k | 27.52 | 4.09 | 19.86 | 0.9951 | 1.26 | 1.26 | 33.32 | 8.49 | 1.60 | 12.27 | 12.24 | 919,449.90 | 6.06 | 5.15 | 7.86 | 6.27 | 19.41 | 21.93 | 3.78 | 3.86 | 1.05 | 7.35 | 0.461 | 0.00 | 16.17 | 16.69 | -20.69 | -- | 4.71 | -- |
| PACS Group Inc | 5.14bn | 169.04m | 6.14bn | 45.68k | 37.89 | 7.04 | 27.76 | 1.19 | 1.03 | 1.03 | 31.45 | 5.56 | 1.01 | -- | 8.54 | 112,496.50 | 3.31 | -- | 4.07 | -- | 21.38 | -- | 3.27 | -- | -- | 12.19 | 0.3813 | -- | 31.44 | -- | -50.60 | -- | -- | -- |
| Molina Healthcare Inc | 45.43bn | 472.00m | 6.32bn | 19.00k | 14.37 | 1.54 | 9.47 | 0.139 | 8.54 | 8.54 | 858.31 | 79.78 | 2.91 | -- | 13.19 | 2,390,842.00 | 3.03 | 6.20 | 5.93 | 13.33 | 13.07 | 14.69 | 1.04 | 2.33 | -- | 4.08 | 0.4926 | 0.00 | 11.75 | 18.52 | -59.97 | -6.85 | 6.42 | -- |
| Chemed Corp | 2.53bn | 278.81m | 6.56bn | 15.70k | 24.47 | 6.07 | 19.11 | 2.59 | 18.92 | 18.92 | 171.97 | 76.31 | 1.49 | 187.30 | 12.28 | 161,238.20 | 16.43 | 19.20 | 19.66 | 24.05 | 32.88 | 35.20 | 11.02 | 12.78 | 1.33 | -- | 0.0006 | 8.19 | 7.37 | 4.63 | 10.82 | 6.55 | -1.35 | 7.74 |
| Brightspring Health Services Inc | 12.41bn | 73.04m | 7.22bn | 37.00k | 116.97 | 3.98 | 28.87 | 0.5821 | 0.3425 | 0.6038 | 58.44 | 10.06 | 2.10 | 19.48 | 12.18 | 335,479.30 | 1.19 | -0.6145 | 1.57 | -0.7609 | 12.30 | 16.65 | 0.5692 | -0.397 | 1.38 | 2.09 | 0.5817 | -- | 27.65 | 20.01 | 88.32 | -- | 9.58 | -- |
| Davita Inc | 13.64bn | 721.80m | 9.89bn | 76.00k | 15.10 | -- | 5.59 | 0.7249 | 9.56 | 9.91 | 179.71 | -9.50 | 0.7849 | 62.63 | 5.98 | -- | 6.06 | 6.13 | 8.47 | 8.24 | 32.25 | 31.51 | 7.72 | 8.48 | 1.24 | 3.78 | 0.8987 | -- | 6.46 | 3.39 | -22.91 | -1.62 | -3.11 | -- |
| Encompass Health Corp | -100.00bn | -100.00bn | 11.41bn | 23.56k | -- | 4.68 | -- | -- | -- | -- | -- | 24.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.4319 | -- | -- | -- | -- | -- | 12.52 | -- |
| Ensign Group Inc | 5.06bn | 343.97m | 12.32bn | 46.00k | 36.27 | 5.52 | 27.45 | 2.43 | 5.84 | 5.84 | 85.94 | 38.42 | 0.9984 | -- | 8.38 | 109,953.10 | 6.80 | 6.66 | 8.11 | 8.05 | 21.07 | 21.89 | 6.81 | 6.82 | -- | -- | 0.0597 | 5.16 | 18.72 | 16.05 | 15.44 | 15.07 | 20.77 | 4.77 |
| Universal Health Services Inc | 16.99bn | 1.38bn | 14.45bn | 86.00k | 10.99 | 2.02 | 7.22 | 0.8506 | 21.04 | 21.04 | 259.66 | 114.75 | 1.14 | -- | 7.08 | 197,587.30 | 9.43 | 6.68 | 11.52 | 7.94 | -- | -- | 8.24 | 6.62 | 0.9595 | 12.35 | 0.3913 | 5.63 | 10.82 | 6.82 | 59.17 | 7.04 | 7.56 | 5.92 |
| Holder | Shares | % Held |
|---|---|---|
| Berkshire Hathaway, Inc. (Investment Management)as of 29 Jan 2026 | 30.10m | 42.64% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 3.83m | 5.43% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 2.40m | 3.39% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 1.83m | 2.60% |
| Invesco Capital Management LLCas of 30 Sep 2025 | 1.54m | 2.18% |
| Gates Capital Management, Inc.as of 30 Sep 2025 | 1.19m | 1.69% |
| Geode Capital Management LLCas of 30 Sep 2025 | 1.02m | 1.45% |
| Dimensional Fund Advisors LPas of 30 Sep 2025 | 987.15k | 1.40% |
| LSV Asset Managementas of 31 Dec 2025 | 936.77k | 1.33% |
| Morgan Stanley & Co. LLCas of 30 Sep 2025 | 679.97k | 0.96% |
